Delivery Order SPE2DB22D1106-SPE2DB24FEKV6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,609.34 firm fixed-price delivery order is for the supply of 40,000 units/mL of the pharmaceutical product PROCRIT. The contract has an ultimate completion date of April 16, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 20,000 units/mL of the pharmaceutical product PROCRIT. The $4,595.23 contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a Defense agency, and has a firm fixed price pricing type. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $4,831.49 firm fixed price delivery order is for the supply of 40,000 units of the medication PROCRIT. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide...
- This federal contract award, valued at $2,335.75, was issued by the Medical Supply Chain unit of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order contract for the pharmaceutical product RETACRIT 20,000 UNIT/ML VIAL. Amerisourcebergen is a major pharmaceutical distributor that holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,592.84 firm fixed-price contract is for the delivery of 40,000 units of the medication PROCRIT, a treatment for anemia, to fulfill federal medical supply requirements. The contract has a completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
- This federal contract award, valued at $2,232.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the product RETACRIT 20,000 UNIT/ML VIALML, without any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,608.20 Firm Fixed Price Delivery Order is for the supply of RETACRIT, a 20,000 unit/mL injectable medication. The contract has an ultimate completion date of July 9, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,542.20 fixed-price delivery order is for the procurement of 40,000 units of the drug Procrit with a strength of 40,000 units/mL. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for $6,179.97. The contract is a delivery order with a firm fixed price, and it has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEKV6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The award, valued at $3,922.08, is a firm fixed price delivery order for the supply of PROCRIT 20,000 units/ml vials. The contract has an ultimate completion date of April 11, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 4/10/24 |